|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.550 USD | +2.90% |
|
-15.45% | -15.14% |
| 06-29 | Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell 2500 Growth Benchmark | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.90% | -15.45% | -9.95% | +51.50% | -15.14% | +20.07% | +122.01% | +33.71% | +127.74% | 227M | |
| +1.07% | -3.49% | +3.71% | +14.21% | +1.90% | -3.25% | +12.87% | -20.12% | +202.43% | 46.35B | |
| -0.86% | +0.57% | +10.28% | +38.37% | +135.05% | +403.00% | +621.72% | +569.10% | - | 40.13B | |
| +0.04% | +4.91% | +18.13% | +8.83% | +7.75% | +10.42% | +67.67% | +19.20% | +1,109.27% | 36.33B | |
| +0.94% | +1.68% | +12.99% | +29.24% | -6.96% | +4.44% | -8.08% | -15.19% | +183.11% | 34.6B | |
| +3.14% | +1.02% | +10.65% | -9.48% | +3.03% | +3.72% | +34.86% | -19.55% | +142.32% | 26.77B | |
| +0.85% | -2.63% | +6.78% | +10.85% | - | - | - | - | - | 16.66B | |
| +0.33% | +13.34% | +18.85% | +48.45% | +8.51% | +33.75% | +146.80% | +235.91% | - | 16.91B | |
| +0.42% | -5.52% | -0.93% | +7.44% | +6.41% | +0.76% | +8.50% | -34.06% | +94.32% | 13.05B | |
| -1.69% | -1.59% | +5.77% | +63.75% | -8.19% | -14.21% | -31.05% | -22.54% | +134.94% | 13.05B | |
| -1.48% | -5.37% | +39.78% | +17.50% | -6.31% | +93.48% | +542.37% | +264.46% | +2,631.23% | 11.22B | |
| -0.22% | -0.62% | +21.74% | +32.28% | +21.88% | +22.58% | -18.47% | -39.28% | +159.64% | 11.18B | |
| -0.51% | +1.74% | +12.94% | +34.43% | +14.43% | +28.89% | +10.14% | -41.96% | +164.34% | 11.04B | |
| +0.03% | +0.21% | +1.20% | +56.86% | +77.91% | +222.49% | +560.85% | - | - | 10.08B | |
| -1.21% | -0.18% | +62.57% | +30.08% | +35.53% | +41.71% | +52.70% | -55.50% | - | 9.59B | |
| +0.10% | -4.60% | +10.58% | +30.07% | +41.94% | +140.87% | +404.29% | +87.06% | - | 9.08B | |
| +0.98% | +3.96% | -26.10% | -22.83% | -28.52% | +34.15% | +44.10% | +51.11% | +99.24% | 9.23B | |
| -0.69% | -0.26% | +4.23% | +57.87% | +87.94% | +98.21% | +65.41% | +115.78% | +4.92% | 8.83B | |
| +0.56% | -3.56% | +11.26% | +35.90% | +55.60% | +152.88% | +594.08% | +190.38% | - | 8.71B | |
| +0.30% | +2.26% | +4.07% | -6.76% | +9.09% | +454.31% | +1,961.06% | +31.18% | - | 8.99B | |
| Average | +0.22% | -0.28% | +10.93% | +26.43% | +23.25% | +92.01% | +273.25% | +74.98% | +421.13% | 17.1B | |
| Weighted average by Cap. | +0.31% | +0.58% | +11.53% | +22.93% | +26.63% | +89.72% | +216.61% | +96.95% | +436.87% |
- Stock Market
- Stocks
- GALT Stock
- Sector Galectin Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
